Loading…
Program is a draft program and is subject to change.
Download the Congress mobile web app to your smartphone or tablet and you will gain access to the conference program, speakers, sessions, proceedings and more.

For Apple:Search for FASAVA 2017 in the iTunes Store
For Andriod: Search for FASAVA 2017 in Google Play
Back To Schedule
Monday, August 14 • 9:10am - 10:00am
Chronic kidney disease in dogs and cats II: Control of secondary hyperparathyroidism and progressive renal inflammation

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
The second session will review the development of renal secondary hyperparathyroidism and how to correct this condition with the use of phosphorus restriction and calcitriol (activated naturally occurring metabolite 1,25(OH)2-cholecalciferol). The emerging concept for the need to supplement parent vitamin D (cholecalciferol) will be introduced. The benefits of prescribing converting enzyme inhibitor treatment (enalapril, benazepril) to prolong renal function and or quality of life will be detailed. The overlapping benefits of dampening the RAAS system with ACE-inhibition and calcitriol will be introduced. The control of renal secondary hyperparathyroidism, progressive renal inflammation, and renal proteinuria will feature treatment with RAAS inhibition (ACE-inhibitors or ARB) and the activated vitamin D metabolite calcitriol (1,25(OH)2-cholecalciferol). A program of diagnostic testing will be proposed to allow safe and effective treatment of CKD.  
Speakers
avatar for Dennis Chew

Dennis Chew

Dr. Chew is a 1972 graduate of the College of Veterinary Medicine at Michigan State University. He did a one-year internship at South Weymouth Veterinary Associates and a two-year residency in internal medicine and nephrology at the Animal Medical Center in New York City. He became... Read More →

Monday August 14, 2017 9:10am - 10:00am AEST
Central A
  Urogenital